substance p has been researched along with Diffuse Parenchymal Lung Disease in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Fukuoka, Y; Hatakeyama, A; Hatakeyama, R; Sasaki, H; Sato, A | 1 |
Albera, C; Brunelleschi, S; Gagliardi, L; Ghio, P; Lavagno, L; Nicali, R; Pozzi, E; Viano, I | 1 |
2 other study(ies) available for substance p and Diffuse Parenchymal Lung Disease
Article | Year |
---|---|
[Therapy for geriatric syndrome].
Topics: Activities of Daily Living; Aged; Aged, 80 and over; Alzheimer Disease; Humans; Lung Diseases, Interstitial; Lung Neoplasms; Mental Disorders; Nutritional Support; Pneumonia, Aspiration; Prognosis; Quality of Life; Substance P; Syndrome | 2006 |
Tachykinin activation of human monocytes from patients with interstitial lung disease, healthy smokers or healthy volunteers.
Topics: Adult; Aged; Cells, Cultured; Female; Humans; Lung Diseases, Interstitial; Male; Middle Aged; Monocytes; Neurokinin A; Peptide Fragments; Pulmonary Fibrosis; Receptors, Neurokinin-1; Receptors, Neurokinin-2; Receptors, Neurokinin-3; Reference Values; Sarcoidosis; Smoking; Substance P; Superoxides; Tachykinins | 2000 |